Product Information
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET is a generic product labeled by SpecGx LLC, priced at $0.1386 per EA under NDC 00406123601. Its NADAC has been published 278 times since Apr 28, 2021.
FDA first approved this application on Oct 6, 2020. Its Orange Book therapeutic-equivalence code is AA.
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET
diphenoxylate hydrochloride and atropine sulfateStrength
.025; 2.5 mg/1; mg/1
Manufacturer
SpecGx LLCNDC
00406123601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213335FDA Approved
10/6/2020
TE Code
AA
On Market Since
10/30/2020
Pharmacological Classes
Price Statistics
The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has been published 278 times since Apr 28, 2021, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1386 per EA |
|---|---|
| All-time high | $0.2446 (Apr 10, 2024) |
| All-time low | $0.1298 (Nov 20, 2024) |
| 52-week high | $0.1837 |
| 52-week low | $0.1371 |
| Median price | $0.1840 |
| Average price | $0.1846 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 278 |
| Tracking since | Apr 28, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, manufactured by SpecGx LLC, is $0.1386 per EA (NDC 00406123601), effective Aug 19, 2026.
How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has declined 34.6%. It has been tracked across 278 weekly CMS publications since Apr 28, 2021.
What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
Since Apr 28, 2021, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has ranged from a low of $0.1298 (Nov 20, 2024) to a high of $0.2446 (Apr 10, 2024), with a median of $0.1840 per EA.
Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET (NDC 00406123601) is labeled by SpecGx LLC, and CMS classifies it as a generic product.